The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of olaparib monotherapy in a subgroup of patients with a germline BRCA1/2 mutation and advanced ovarian cancer from a Phase II open-label study.
 
Susan M. Domchek
No Relationships to Disclose
 
Ronnie Shapira-Frommer
No Relationships to Disclose
 
Rita K. Schmutzler
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
M. William Audeh
No Relationships to Disclose
 
Michael Friedlander
Honoraria - Clovis Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche
Research Funding - AstraZeneca (Inst)
 
Judith Balmaña
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); PharmaMar (Inst)
 
Gillian Mitchell
Consulting or Advisory Role - AstraZeneca
Research Funding - Abbvie
 
Georgeta Fried
No Relationships to Disclose
 
Salomon M. Stemmer
No Relationships to Disclose
 
Ayala Hubert
No Relationships to Disclose
 
Ora Rosengarten
Consulting or Advisory Role - AstraZeneca
 
Niklas Loman
No Relationships to Disclose
 
Jane D. Robertson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Helen Mann
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Bella Kaufman
No Relationships to Disclose